APREA THERAPEUTICS, INC. (APRE) Social Stream



APREA THERAPEUTICS, INC. (APRE): $4.82

0.37 (-7.13%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add APRE to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#192 of 405

in industry

APREA THERAPEUTICS INC (APRE) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering APRE.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 3 $5 $4 $4.5 $5.73 -21.47%
2022-03-16 3 $5 $2 $3.5 $5.73 -38.92%
2022-07-08 3 $5 $2 $3.333 $5.73 -41.83%
2022-08-15 3 $3 $2 $2.5 $5.73 -56.37%
2022-11-10 3 $60 $60 $60 $5.73 947.12%
2023-03-17 3 $60 $16 $45.333 $5.73 691.15%
2023-03-31 3 $60 $16 $32 $5.73 458.46%
2023-11-10 3 $20 $9 $15 $5.73 161.78%

The Trend in the Analyst Price Target


Over the past 29 months, APRE's average price target has gone up $7.75.

Over the past 35 weeks, APRE's average upside potential has been 420.41%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-10 3 60 16 45.333 5.040 799.46%
2023-03-31 3 60 16 32.000 4.440 620.72%
2023-05-16 3 20 9 15.000 3.887 285.9%
2023-10-16 3 20 9 15.000 5.200 188.46%
2023-11-10 3 20 9 15.000 3.840 290.62%

APRE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


APRE's average broker recommendation rating improved by 0 over the prior 31 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • APREA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 586.18% of all US stocks.
  • APREA THERAPEUTICS INC's number of analysts covering the stock is greater than 111.02% of all US stocks.
  • In terms of how APREA THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 491.24% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, APREA THERAPEUTICS INC's variance in analysts' estimates is lower than -490.66% of them.

Stocks similar to APREA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MIRM, FULC, and BCEL.

Is APRE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!